Join Biodesix CFO, Robin Harper Cowie, during the "Taking Stock of Paradigm-Shifting Developments from FDA" panel on Wednesday, July 17th, as they discuss new regulations for laboratory-developed tests and FDA efforts to advance approvals of cell and gene therapy products during the Sidley Global Life Sciences Bay Area Lifesciences Roundtable. Register here: https://lnkd.in/g4hKv5ar #biotech #multiomics #diagnostics #precisionmedicine
Join us on Wednesday, July 17 for Sidley’s Bay Area Lifesciences Roundtable at SFMOMA San Francisco Museum of Modern Art, featuring an afternoon of discussions addressing cutting-edge trends and hot topics including opportunities across Asia, #AI-enabled #lifesciences technologies, and the latest #FDA developments. Panelists include: Sidley’s Tom Duley, Joshua Hofheimer, Stephen Abreu, Meenakshi Datta, Torrey Cope, and Emily Marden; Judith Li of Lilly Asia Ventures; Chugai Pharmaceutical Co.’s Mark Noguchi; Andrew Wong of Bayer Co.Labs; Aitia’s Colin Hill; Joshua Reicher, M.D. of IMVARIA Inc.; Google Ventures’ Ryan Spiers; Robin Harper Cowie of Biodesix; BioMarin Pharmaceutical Inc.’s Jun Li; and Amar Murugan of Atara Biotherapeutics, Inc. Learn more and register here, https://bit.ly/3Rx58MP.